These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33449175)

  • 21. Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.
    Li S; Yuan L; Yue M; Xu Y; Liu S; Wang F; Liu X; Wang F; Deng J; Sun Q; Liu X; Xue C; Lu T; Zhang W; Zhou J
    Cancer Imaging; 2023 Mar; 23(1):30. PubMed ID: 36964617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole tumor based texture analysis of magnetic resonance diffusion imaging for colorectal liver metastases: A prospective study for diffusion model comparison and early response biomarker.
    Li Y; Zhang H; Yue L; Fu C; Grimm R; Li W; Guo W; Tong T
    Eur J Radiol; 2024 Jan; 170():111203. PubMed ID: 38007855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    Granata V; Fusco R; Catalano O; Filice S; Amato DM; Nasti G; Avallone A; Izzo F; Petrillo A
    PLoS One; 2015; 10(11):e0142876. PubMed ID: 26566221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Early Response to Chemotherapy in Breast Cancer Liver Metastases by Diffusion-Weighted MR Imaging.
    Bai G; Wang Y; Zhu Y; Guo L
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819842944. PubMed ID: 30961445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
    Su X; Zhang H; Wang Y
    J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
    Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
    Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases.
    Zhu HB; Xu D; Ye M; Sun L; Zhang XY; Li XT; Nie P; Xing BC; Sun YS
    Int J Cancer; 2021 Apr; 148(7):1717-1730. PubMed ID: 33284998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC - A systematic review and meta-analysis.
    Sobeh T; Inbar Y; Apter S; Soffer S; Anteby R; Kraus M; Konen E; Klang E
    Eur J Radiol; 2023 Jun; 163():110810. PubMed ID: 37075628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
    Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.
    Pietrantonio F; Orlandi A; Inno A; Da Prat V; Spada D; Iaculli A; Di Bartolomeo M; Morosi C; de Braud F
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):272-81. PubMed ID: 25958297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
    Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
    Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline hepatobiliary MRI for predicting chemotherapeutic response and prognosis in initially unresectable colorectal cancer liver metastases.
    Chen Y; Lu T; Zhang Y; Li H; Xu J; Li M
    Abdom Radiol (NY); 2024 Aug; 49(8):2585-2594. PubMed ID: 39034308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
    Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
    Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
    Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
    AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    Goshen E; Davidson T; Zwas ST; Aderka D
    Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.